ClinicalTrials.govpublic full text
Oral Metronomic Capecitabine Combined With Pyrotinib in ADC-treated HER2-positive Metastatic Breast Cancer
her2-positive breast cancer, metastatic breast cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 861926
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.